0000000000213189

AUTHOR

Valérie Quipourt

showing 12 related works from this author

Influence of geriatric oncology consultation on the management of breast cancer in older women: A French population-based study

2014

Aim The objective of the present population-based study was to assess the impact of geriatric oncology consultation on the management of elderly patients with breast cancer and to identify the predictive factors of breast cancer treatment in this population. Methods A total of 206 women aged 75 years and older with breast cancer, diagnosed from January 2007 to December 2009 were included. The independent impact of geriatric oncology consultation on treatment was analyzed using multivariate logistic regression with adjustment for the other predictive factors of treatment. Results Patients who had a geriatric oncology consultation (19.4%) had more comorbidities (Charlson Comorbidity Index ≥1;…

Oncologymedicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationOdds ratioLogistic regressionmedicine.diseasePopulation based studyBreast cancerGeriatric oncologyInternal medicineAdjuvant therapyMedicinebusinesseducationMastectomyGeriatrics & Gerontology International
researchProduct

Influence of the Geriatric Oncology Consultation On the Final Therapeutic Decision In Elderly Subjects With Cancer: Analysis of 191 Patients

2014

International audience; Objectives: evaluate the impact of the Geriatric Oncology consultation on the final therapeutic management of cancer in elderly patients aged 70 and older. Design: retrospective study. Setting: the Pilot coordination unit in Geriatric Oncology of Cote d'Or, Burgundy, France. Participants: From January 2010 to December 2010, 191 patients with cancer aged 70 and older. Measurements: the concordance between the treatments proposed following the tumor Board, those proposed following the Geriatric evaluation (GE) and those actually given to the patients was evaluated using the kappa agreement test. Results: One hundred and ninety-one patients were included. Mean age was 8…

Malemedicine.medical_specialtyLung NeoplasmsConcordanceDecision MakingMedicine (miscellaneous)Breast NeoplasmsILLNESSMedical OncologyCONTROLLED-TRIALVALIDATIONlaw.inventionRandomized controlled triallawNeoplasmsPhysiciansmedicineMANAGEMENTHumansPhysician's RoleGeriatric AssessmentReferral and ConsultationSCALEAgedRetrospective StudiesQuality of Life ResearchAged 80 and overNutrition and Dieteticsbusiness.industryGeriatrics gerontologyUNDERTREATMENTAntineoplastic ProtocolsCancersocial sciences[SCCO] Cognitive sciencemedicine.diseasehumanitiesGeriatric oncologyGeriatricsFamily medicinePhysical therapyFemaleFrance[ SCCO ] Cognitive scienceGeriatrics and GerontologyColorectal Neoplasmsbusiness
researchProduct

In breast cancer, are treatments and survival the same whatever a patient's age? A population-based study over the period 1998-2009

2014

Aim The present study aimed to describe treatments, relative survival and prognostic factors in breast cancer patients according to age. Methods All women with primary invasive breast cancer, diagnosed from 1998 to 2009 in the department of Cote d'Or, were retrospectively selected. Variations in treatments administered according to age ( 74 years) and period were assessed using Cochran–Armitage trend tests and χ2-tests, respectively. Prognostic factors according to age were estimated using a generalized linear model with a Poisson error structure. Results Overall, 4305 women were included. The oldest women (aged >74 years) were more likely than the youngest women to have comorbidities, adva…

Gynecologymedicine.medical_specialtyRelative survivalbusiness.industryTumor biologymedicine.medical_treatmentmedicine.diseasePopulation based studyBreast cancerInternal medicineBreast-conserving surgeryAdjuvant therapyMedicineHormone therapybusinessHormoneGeriatrics & Gerontology International
researchProduct

Therapeutic drug monitoring as a tool to optimize 5-FU-based chemotherapy in gastrointestinal cancer patients older than 75 years.

2019

Abstract Aims Most clinical trials exclude elderly people, leading to a limited understanding of the benefit-to-risk ratio in this population. Despite existing data regarding the oncological management of elderly receiving fluorouracil (5-FU)-based regimen, our objective was to investigate 5-FU exposure/toxicity relationship in patients ≥75 years and compare the effectiveness of 5-FU therapeutic drug monitoring between elderly and younger patients. Methods Hundred fifty-four patients (31 of whom are older than 75 years) with gastrointestinal cancers, who were to receive 5-FU–based regimens, were included in our study. At cycle 1 (C1), the 5-FU dose was calculated using patient's body surfac…

0301 basic medicineAdultMaleCancer Researchmedicine.medical_specialty[SDV]Life Sciences [q-bio]PopulationAntineoplastic Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansGastrointestinal cancereducationAgedGastrointestinal NeoplasmsRetrospective StudiesBody surface areaAged 80 and overeducation.field_of_studymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryArea under the curveMiddle Agedmedicine.disease3. Good healthClinical trialRegimen030104 developmental biologyOncologyTolerabilityTherapeutic drug monitoring030220 oncology & carcinogenesisFemaleFluorouracilDrug MonitoringbusinessEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Comorbidities Alone Do Not Explain the Undertreatment of Colorectal Cancer in Older Adults: A French Population-Based Study

2011

OBJECTIVES: To investigate the influence of comorbidities on treatment modalities of colorectal cancer according to the age of patients and French recommendations. DESIGN: Population-based study SETTING: French Digestive Cancer Registry, Burgundy. PARTICIPANTS: Two thousand nine hundred twenty-one incident colorectal cancers diagnosed between 2004 and 2007. MEASUREMENTS: The independent influence of comorbidities (recorded according to the Charlson index) on treatment was analyzed using multivariate logistic regressions controlling for age, sex, and their interaction. RESULTS: The association between comorbidities and resection for cure was significant only in patients younger than 75 (P in…

Geriatricsmedicine.medical_specialtyeducation.field_of_studyChemotherapybusiness.industryColorectal cancermedicine.medical_treatmentPopulationCancermedicine.diseaseComorbidityCancer registrySurgeryRadiation therapyInternal medicinemedicineGeriatrics and GerontologybusinesseducationJournal of the American Geriatrics Society
researchProduct

Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study

2015

International audience; Background: Studies carried out in the context of clinical trials have shown a relationship between survival and health-related quality of life in colorectal cancer patients.Aims: We assessed the prognostic value of health-related quality of life at diagnosis and of its longitudinal evolution on survival in older colorectal cancer patients. Methods: All patients aged >= 65 years, diagnosed with new colorectal cancer between 2003 and 2005 and registered in the Digestive Cancer Registry of Burgundy were eligible. Patients were asked to complete the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 at inclusion, three, six …

MaleMultivariate analysisColorectal cancerAppetiteDefinitions0302 clinical medicineQuality of lifeSurveys and QuestionnairesCancer registries030212 general & internal medicineAged 80 and overRelative survivalHazard ratioGastroenterologyScoresPrognosis3. Good healthSurvival RateOncology030220 oncology & carcinogenesisColonic NeoplasmsFemalePerspectivesmedicine.medical_specialtyPredict survivalClinical-TrialsContext (language use)Prognostic factorsFeeding and Eating DisordersAssociation03 medical and health sciencesInternal medicinePatient report outcomemedicineHumansMortalitySurvival rateAgedHepatologyRectal Neoplasmsbusiness.industryElderly-patientsCancer[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologymedicine.diseaseElderly patientsQuality of LifePhysical therapyEuropean-organizationbusinessFollow-Up StudiesDigestive and Liver Disease
researchProduct

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment

2012

Abstract Background A large proportion of women with breast cancer (BC) are elderly. However, there is a lack of information regarding BC prognostic factors and care in this population. The aims of this study were to assess the prognostic factors of relative survival (RS) among women with BC aged ≥ 75 years old and to identify the predictive factors of treatments administered to this population. Methods A population-based study was performed using data from the Cote d’Or breast and gynaecological cancer registry. Women aged 75 years and older with primary invasive BC and resident in Cote d’Or at the time of diagnosis made between January 1998 and December 2008 were retrospectively selected.…

Cancer Researchmedicine.medical_treatmentComorbidityBreast cancerBreast-conserving surgeryRegistriesMastectomyAged 80 and overeducation.field_of_studyPredictors of treatmentRelative survivalPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCombined Modality TherapyTreatment OutcomeOncologyPopulation SurveillanceHypertensionFemaleFranceMastectomyResearch Articlemedicine.medical_specialtyPopulationBreast NeoplasmsPrognostic factorsRelative survivallcsh:RC254-282Breast cancerDrug TherapyInternal medicineDiabetes MellitusmedicineAdjuvant therapyGeneticsHumansObesityElderly womeneducationSurvival analysisAgedNeoplasm StagingRetrospective StudiesGynecologyRadiotherapybusiness.industrymedicine.diseaseSurvival AnalysisLogistic ModelsMultivariate AnalysisHormone therapybusinessFollow-Up StudiesBMC Cancer
researchProduct

Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy

2016

AIM To study the tolerance and the efficiency of FOLFIRINOX in elderly patients diagnosed with colorectal or pancreatic cancer. METHODS This retrospective study included elderly patients aged over 70 years of age treated at Georges-Francois Leclerc Center by FOLFIRINOX for histological proved colorectal or pancreatic cancer between January 2009 and January 2015. Chemotheapy regimen consisted of oxaliplatin (85 mg/m(2) in over 120 min) followed by leucovorin (400 mg/m(2) in over 120 min), with the addition, after 30 min of irinotecan (180 mg/m(2) in over 90 min) then 5 fluorouracil (5FU) (400 mg/m(2) administred intravenous bolus), followed by 5FU (2400 mg/m2 intraveinous infusion over 46 h)…

MaleTime FactorsOrganoplatinum CompoundsColorectal cancerFOLFIRINOXLeucovorinPooled AnalysisInternational-SocietyKaplan-Meier EstimateOlder PatientsGastroenterology0302 clinical medicineRisk FactorsAntineoplastic Combined Chemotherapy Protocols030212 general & internal medicineAged 80 and overAge FactorsGastroenterologyCommon Terminology Criteria for Adverse EventsGeneral Medicine3. Good healthOxaliplatinTreatment Outcome030220 oncology & carcinogenesisDisease ProgressionFolfirinoxFemale[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFluorouracilFranceFolfirinox RegimenColorectal Neoplasmsmedicine.drugmedicine.medical_specialtyOxaliplatin FolfirinoxIrinotecanDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesPancreatic CancerRetrospective StudyInternal medicinePancreatic cancermedicineHumansChemotherapyGeriatric AssessmentAgedRetrospective StudiesColorectal CancerChi-Square DistributionPerformance statusbusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyElderly Patientsmedicine.diseasePhase-Ii Trial1st-Line TreatmentSurgeryPancreatic NeoplasmsIrinotecanRegimenMultivariate AnalysisCamptothecinOpen-LabelFeasibility TreatmentTomography X-Ray Computedbusiness
researchProduct

Diabète de type 2 chez le sujet âgé : quelles spécificités ?

2012

Type 2 diabetes, whose prevalence has increased among elderly aged over 75 years, has a number of specific features which differ from that in young people: heterogeneous population, association with other cardiovascular risk factors and several comorbidities, different therapeutic constraints and risks, and lower life expectancy. By using a standardized geriatric assessment it is possible to determine therapeutic and glycemic goals for each patient. In the elderly, main complications of diabetes are hypoglycemia and foot lesions. In order to avoid malnutrition, lifestyle and dietary rules should not be too strict. Recommendations for the prescription of oral antidiabetic agents are the same…

2. Zero hungerGeriatricsmedicine.medical_specialtyPediatricsbusiness.industryGastroenterology030209 endocrinology & metabolismDiseaseType 2 diabetes030204 cardiovascular system & hematologyHypoglycemiamedicine.disease3. Good health03 medical and health sciencesMalnutrition0302 clinical medicineDiabetes mellitusInternal MedicinemedicineMedical prescriptionbusinessGlycemicLa Revue de Médecine Interne
researchProduct

Age-related socio-economic and geographic disparities in breast cancer stage at diagnosis: a population-based study.

2015

Background: This study aimed to determine the impact of socio-economic and geographic disparities on disease stage at diagnosis according to age in breast cancer (BC) patients. Secondary purpose was to describe survival . Methods: All women with primary invasive BC, diagnosed from 1998 to 2009 in the department of Cote d’Or were retrospectively selected using data from the Cote d’Or BC registry. European transnational ecological deprivation index (French European Deprivation Index) was used to measure the socio-economic environment. Relationships between socio-geographic deprivation and disease stage at diagnosis according to age were assessed by a multilevel ordered logistic regression mod…

GerontologyBreast NeoplasmsDiseaseBreast cancerResidence CharacteristicsmedicineOdds RatioHumansSurvival rateEarly Detection of CancerAgedNeoplasm StagingRetrospective StudiesRelative survivalbusiness.industryPublic Health Environmental and Occupational HealthAge FactorsRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseasePrognosisLogistic ModelsSocioeconomic FactorsFemaleOrdered logitFrancebusinessStage at diagnosisDemographyEuropean journal of public health
researchProduct

Management of elderly patients suffering from cancer: Assessment of perceived burden and of quality of life of primary caregivers

2017

International audience; Objective: To evaluate the perceived burden and the quality of life (QoL) at 3 and 6 months of the primary caregiver (PC) of patients aged 70 and over suffering from cancer and the predictors of QoL in this population.Methods: In this prospective observational study, 98 patients aged 70 and older with cancer and 96 PCs were included between 01/06/2014 and 18/03/2015. The Medical Outcomes Study 12-item Short Form Health Survey (SF-12) was used to assess the QoL of PCs and the Zarit Burden Interview (ZBI) was used to measure the perceived burden at 3 and 6 months. The major determinants of QoL were identified using mixed linear models for the dimensions of the SF-12 th…

MaleMultivariate analysisActivities of daily livingTime Factors0302 clinical medicineQuality of lifeCost of IllnessNeoplasmsSurveys and QuestionnairesActivities of Daily Living030212 general & internal medicineLongitudinal StudiesProspective StudiesProspective cohort studyPrimary caregiverAged 80 and overeducation.field_of_studyFamily caregivers[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyillnessAge FactorsMiddle Agedcomprehensive geriatric assessmentolder patientshumanities3. Good healthcomorbidityOncologyCaregivers030220 oncology & carcinogenesisdepressionDisease ProgressionimpactFemalefamily caregiversoncology consultationQuality of lifemedicine.medical_specialtyGeriatric oncology consultationPopulationBurden[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology03 medical and health sciencesmedicineHumanscareeducationbreast-cancerbusiness.industrymedicine.diseaseComorbidityPhysical therapyObservational studyGeriatrics and Gerontologybusiness
researchProduct

Assessment of the interest of the geriatric oncology consultation among French general practitioners

2015

International audience; OBJECTIVE: We assessed the interest of the geriatric oncology (GO) consultation (GOC) among general practitioners (GPs). MATERIALS AND METHODS: We conducted a survey among GPs whose patients had had a GOC in 2012. A questionnaire was sent to GPs. The 1st part collected GPs' characteristics including medical education in geriatrics and GO, and knowledge of GOC. The following parts concerned the GOC and included the cancer type, GOC report and care plan. RESULTS: One-hundred twenty-six questionnaires corresponding to 94 GPs were collected. Concerning the GPs' characteristics, age range 50-59 (44.7%), men (62.8%) and urban practice (79.8%) were the most represented, 80.…

AdultMalemedicine.medical_specialtyGeriatric oncology consultationAttitude of Health Personnelphysicianseducation[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyMedical Oncology[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicineresponse ratesNeoplasmsSurveys and QuestionnairesCare planGeneral practitionersmedicineHumans030212 general & internal medicinecareReferral and ConsultationGeriatricscancer-patientsbusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyCancer typeMiddle Aged3. Good healthElderly patientsOncologyGeriatric oncologyGeriatrics030220 oncology & carcinogenesisFamily medicineGlobal Positioning SystemFemaleFranceGeriatrics and Gerontologybusinessmanagement
researchProduct